Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|8|1368-1373

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.8, 2015-08, pp. : 1368-1373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allogeneic Cell-Mediated Immunotherapy at the Stage of Minimal Residual Disease following High-Dose Chemotherapy Supported by Autologous Stem Cell Transplantation

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 214-220

Karger

Access to resources Recommend Favorite

The Significance of Minimal Residual Disease in Stem Cell Grafts and the Role of Purging: Is It Better to Purge in vivo or in vitro?

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 206-213

Karger

Access to resources Recommend Favorite

Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 952-957

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 147-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell transplantation

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1493-1500

John Wiley & Sons Inc

Access to resources Recommend Favorite